In response to recent feedback received from E&M committee members and measure developers/stewards regarding the Fall 2023 cycle, Battelle seeks to implement several changes to the E&M committee roles, voting, and meeting structure. Taking effect in the Spring 2024 cycle, the proposed changes discussed below are intended to:
- Enhance the engagement and participation of Advisory Group members, patient partners, and members of the public;
- Reduce burden for E&M committee members (both Advisory and Recommendations Groups); and
- Mitigate confusion of roles for E&M committee members by aligning processes across both E&M and the Pre-Rulemaking Measure Review (PRMR).
Overall, the proposed changes are designed to enhance consensus-building, capturing measure review input in a less burdensome way, while maintaining diversity of voices.
The proposed changes to be implemented for the Spring 2024 cycle and beyond include:
- Advisory Group Meetings
- Voting
- Recommendations Group Size
- Public Comment Listening Sessions
- Committee Independent Review Ratings
Public Comments on the proposed changes were submitted from March 1 through 11:59 p.m. (ET) March 22. To view all comments received, please navigate to the following page on the PQM website: https://p4qm.org/media/2366.
If you're having any difficulties or have any questions, please contact [email protected].